In agreement with this hypothesis, a recently published paper by Chen et al. [124] demonstrated that phosphorylation of parkin at Ser131 was responsible for disruption of the parkin’s protective function in A53T transgenic mice model of synucleinopathy. This evidence concerns the gene PRKN and synucleinopathy.